Just days after closing their oversubscribed $9.8 million capital raise, drug developer Pharmaxis (ASX: PXS) has seen further funding devoted to its projects, this time from the Government to apply work towards skin diseases and pancreatic cancer. The NMHRC Drug Development Grant scheme is an Australian government initiative set up to provide financial aid to
Read More
The people of Hong Kong and Macau are set to receive yet another non-dairy alternative when it comes to their morning latte or bubble tea. Wide Open Agriculture (ASX: WOA) has signed a distribution agreement with Metro Alliance Ltd. to distribute their carbon-neutral, regenerative oat milk through the region. Metro will also complete sales, marketing
Read More
Australia’s OG buy-now-pay-later business is set to be cashed out at a high as the sector undergoes a consolidation phase with Humm Group (ASX: HUM) having been tapped on the shoulder by Latitude (ASX: LFS) for its consumer finance business to the tune of a $335 million offer. The offer comes in the form of
Read More
Just the other day I was stupefied by the fact that my otherwise financially savvy boyfriend didn’t have Raiz (ASX: RZI) on his phone. “YOU DON’T KNOW ABOUT RAIZ?!” I blurted out, mouth full of pancakes that he’d made (side note: this one is definitely a keeper). “Who doesn’t know about Raiz? Give me your
Read More
The New Year period may be a time to wind down for some, but it hasn’t been for infrastructure development company Decmil (ASX: DCG) which has been awarded road construction contracts on opposite sides of the country in both Western Australia and Queensland. The larger of the two has been awarded by Main Roads, Western
Read More
With ‘Rapid Antigen Test’ having only taken several days to likely be one of the most commonly used words of 2022, everyone is looking for them but demand is monumentally outweighing supply. With their surge in use, it may only be a matter of time until Australian regulators fast-track approval of more RAT manufacturers with
Read More